Matthew Rudloff, MD
Orthopaedic Trauma · Memphis, TNNPI 1265644090
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 69.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $3,437 and has fallen 84.2% since, to $542 in 2025.
Across 109 payments — averaging $93.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$7K
- Johnson & Johnson$1K
- Acera Surgical, Inc.$379
- Stryker$257
- Gentleman Orthopedic Solutions$231
- Abyrx, Inc$191
- plus $922 from 14 others
What the payments were for
- Consulting fees$5,27852%
- Speaking & faculty fees$9209%
- Food & beverage$3,98839%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 28 | $7,103 |
| Johnson & Johnson | 23 | $1,101 |
| Acera Surgical, Inc. | 13 | $379 |
| Stryker | 7 | $257 |
| Gentleman Orthopedic Solutions | 4 | $231 |
| Abyrx, Inc | 1 | $191 |
| Bioventus LLC | 7 | $174 |
| KCI USA, Inc. | 6 | $118 |
| Trimed, Inc. | 1 | $99 |
| Davol Inc. | 2 | $87 |
| Sanara Medtech Inc. | 4 | $83 |
| Integra Lifesciences Corporation | 2 | $67 |
| Arteriocyte Medical Systems, Inc. | 3 | $61 |
| Solventum Corporation | 2 | $48 |
| Zimmer Biomet | 1 | $40 |
| Dilon Technologies, Inc. | 1 | $36 |
| Biotissue Holdings Inc. | 1 | $33 |
| Anika Therapeutics, Inc. | 1 | $32 |
| Flower Orthopedics Coporation | 1 | $23 |
| Acell, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jet-X$8,760
- EVOS$583
- NA$268
- IM NAILS$216
- Montage Settable Resorbable Hemostatic Bone Putty$191
- TRIGEN Femoral (FAN/TAN/Meta Nail)$145
- TFN-Advance$127
- MOTOBAND$127
- TFN$116
- MULTILOC HUMERAL NAIL$116
- RIA$116
- ECHELON Primary$106
How this compares
$10,186 in reported general payments places this provider in the 55th percentile of 27 orthopaedic trauma providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 23 | $61 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Memphis
- John WeinleinMemphis$4K
- Robert HarrisJohnson City$177K
- Tania FergusonNashville$155K
- Bryce CunninghamChattanooga$55K
- Phillip MitchellNashville$32K
- Katherine BuesserNashville$30K
- Jason EvansNashville$28K
- Erin HoferNashville$25K
- William ObremskeyNashville$14K
- Donald AdamsNashville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.